AGAnnette S. H. Gouw

Annette S. H. Gouw

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Annette S. H. Gouw has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis

    by Qianyi Wang, Hong You, Xiaojuan Ou, Xinyan Zhao, Yameng Sun, Min Wang, Ping Wang, Yu Wang, Weijia Duan, Xiaoming Wang, et al.

    Non-alcoholic fatty liver disease (NAFLD) commonly affects subjects with obesity, yet non-obese NAFLD is increasingly being recognized. We aimed to investigate the clinicopathological and genetic characteristics of non-obese NAFLD patients.


  • Open Access

    Relevance of the CDE and DDC Mouse Models to Study Ductular Reaction in Chronic Human Liver Diseases

    by Laure-Alix Clerbaux, Noémi Van Hul, Annette S.H. Gouw, Rita Manco, Regina Español-Suñer, Isabelle A. Leclercq

    The liver has the remarkable capacity to regenerate through cellular division of hepatocytes. However, following severe injuries that abrogates the replicative capacity of hepatocytes some immature-like cells proliferate around the portal area and invade the parenchyma in a process known as ductular reaction (DR). In humans, DR is observed in virtually all chronic liver disorders although the morphological patterns may vary. DR biology has gained considerable interest because of potential contribution to hepatic cell restoration, fibrosis or carcinogenesis. In humans, observational studies are available but experimental manipulations and lineage tracing are impossible. Animal models represent thus valuable tools to explore such questions. Feeding rodents a choline-deficient, ethionine-supplemented diet (CDE) or a diet enriched in 3,5-diethoxycarboncyl-1,4-dihydrocollidine (DDC) are the most popular models to study DR. They are often used equivalently in the literature although the aspects and outcome of the DR are different and model-specific. Here, we describe experimental procedures and the pathophysiological mechanisms at play; we describe the hepatic lesions and highlight the unique character of DR phenotype, proliferation, lineage commitment and microenvironment in each model. We then compare the models with DR phenotype in human pathologies.


  • Bile ductal injury and ductular reaction are frequent phenomena with different significance in autoimmune hepatitis

    by Robert C. Verdonk, Mallaki F. Lozano, Aad P. van Den Berg, Annette S. H. Gouw

    Background & Aims: The significance of bile duct injury and ductular reaction in biopsies from autoimmune hepatitis patients is not clear. We aim to establish the prevalence and clinical relevance of both phenomena in autoimmune hepatitis.Methods: Cases of newly diagnosed, untreated autoimmune hepatitis without overlap syndrome were selected. Pretreatment and follow up biopsies were scored for inflammation, fibrosis, bile ductal injury and ductular reaction.Results: Thirty‐five cases were studied of whom 14 cases had follow up biopsies. Bile duct injury was present in 29 cases (83%), mostly in a PBC‐like pattern and was not correlated with demographical or laboratory findings. Ductular reaction, observed in 25 of 35 cases (71%) using conventional histology and in 30 of 32 cases (94%) using immunohistochemistry, was correlated with portal and lobular inflammation, interface hepatitis and centrilobular necrosis as well as bile duct injury and fibrosis. In 11 of 14 cases (79%) ductular reaction remained present on post‐treatment biopsy whereas bile duct injury persisted in six of 14 (43%) of cases.Conclusions: Bile duct injury and ductular reaction are very common in newly diagnosed autoimmune hepatitis and cannot be predicted biochemically. Bile duct injury may subside in the majority of treated AIH cases while DR tends to persist during follow up. These findings show that the two phenomena are part of the spectrum of AIH with dissimilar responses to treatment and do not necessarily point towards an overlap syndrome. Persistence of ductular reaction after treatment supports the notion that it represents a regenerative response.


  • Open Access

    Old dilemma: asthma with irreversible airway obstruction or COPD

    by Fatemeh Fattahi, Judith M. Vonk, Nicole Bulkmans, Ruth Fleischeuer, Annette Gouw, Katrien Grünberg, Thais Mauad, Helmut Popper, Aloisio Felipe-Silva, Bart Vrugt, et al.

    Older asthmatic patients may develop fixed airway obstruction and clinical signs of chronic obstructive pulmonary disease (COPD). We investigated the added value of pathological evaluation of bronchial biopsies to help differentiate asthma from COPD, taking into account smoking, age, and inhaled corticosteroid (ICS) use. Asthma and COPD patients (24 of each category) were matched for ICS use, age, FEV1, and smoking habits. Five pulmonary and five general pathologists examined bronchial biopsies using an interactive website, without knowing patient information. They were asked to diagnose asthma or COPD on biopsy findings in both a pairwise and randomly mixed order of cases during four different phases, with intervals of 4–6 weeks, covering a maximal period of 36 weeks. Clinically concordant diagnoses of asthma or COPD varied between 63 %-73 %, without important differences between pairwise vs randomly mixed examination or between general vs pulmonary pathologists. The highest percentage of concordant diagnoses was in young asthmatic patients without ICS use and in COPD patients with ICS use. In non ICS users with fixed airway obstruction, a COPD diagnosis was favored if abnormal presence of glands, squamous metaplasia, and submucosal infiltrate was present and an asthma diagnosis in case of abnormal presence of goblet cells. In ICS users with fixed airway obstruction, abnormal presence of submucosal infiltrates, basement membrane thickening, eosinophils, and glands was associated with asthma. Histological characteristics in bronchial biopsies are reproducibly recognized by pathologists, yet the differentiation by histopathology between asthma and COPD is difficult without information about ICS use.


  • Hepatocellular adenoma management: Call for shared guidelines and multidisciplinary approach

    by Jean Frédéric Blanc, Nora Frulio, Laurence Chiche, Christine Sempoux, Laurence Annet, Catherine Hubert, Annette S.H. Gouw, Koert P. de Jong, Paulette Bioulac-Sage, Charles Balabaud


  • Open Access

    How Normal Is the Liver in Which the Inflammatory Type Hepatocellular Adenoma Develops?

    by Jing Han, Marius C. van Den Heuvel, Hironori Kusano, Koert P. de Jong, Annette S. H. Gouw

    The inflammatory type hepatocellular adenoma (IHCA) is a subtype of HCA which is a benign liver tumor, predominantly occurring in young women in an otherwise normal liver. IHCA contains either a mutation of gp130 or STAT3. Both mutations lead to a similar morphologic phenotype and to increased expression of C-reactive protein (CRP) and/or serum amyloid-A (SAA). IHCA comprised about 40% of all HCAs and is associated with obesity. We investigated the histomorphological and immunophenotypical changes of the nontumorous liver of 32 resected IHCA specimens. Similar types of changes are present in samples taken adjacent to tumor and distant ones. The lobular architecture is well preserved. Mild/moderate steatosis is found in a high frequency which is in accordance with the median BMI of 32 in our cases. Of note are the regular findings of sinusoidal dilatation, single arteries, and minute CRP foci which are all features of HCA. These distinct CRP foci are mostly found in cases of multiple IHCA which indicates that the remnant liver may also contain IHCA foci. These findings show that the nonlesional liver in IHCA does contain abnormalities, and this may have consequences for the followup, especially since it is known that obesity may stimulate malignant growth.